Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market sale Chief Business Officer sold 10,058 shares at an average $17.73 ($178,376)
  2. 4 Open-market sale Chief Legal Officer sold 10,177 shares at an average $17.71 ($180,190)
  3. 4 Open-market buy Director bought 56,000 shares at $14.00 ($784,000)
  4. 4 Open-market buy Chief Scientific Officer bought 400 shares at $14.00 ($5,600)
  5. 4/A Open-market buy 10% owner bought 161,000 shares at $14.00 ($2,254,000)
  6. 4 Open-market buy Director bought 161,000 shares at $14.00 ($2,254,000)
  7. 4 Open-market buy Director bought 161,000 shares at $14.00 ($2,254,000)
  8. 3/A Insider 3/A
  9. 3/A Insider 3/A
  10. 4/A Open-market buy 10% owner bought 800,150 shares at $14.00 ($11,202,100)
  11. 4 Grant or award Director acquired 70,000 shares (grant or award)
  12. 4 Grant or award 10% owner acquired 161,000 shares (grant or award)
  13. 4 Open-market buy Director bought 66,500 shares at $14.00 ($931,000)
  14. 4 Open-market buy 10% owner bought 66,500 shares at $14.00 ($931,000)
  15. 4 Open-market buy 10% owner bought 800,150 shares at $14.00 ($11,202,100)
  16. 4 Conversion 10% owner acquired 744,380 shares (conversion)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 24 of 26 · 502 filings